INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 16, 2016 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | 2,459 |
| May 16, 2016 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | -- |
| May 16, 2016 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | 2,459 |
| May 16, 2016 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Bona fide gift | 2,459 | -- | 2,459 |
| Dec 16, 2015 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | $52.03 | 17,742 |
| Dec 16, 2015 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Aug 13, 2015 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | $270.43 | 25,821 |
| Aug 13, 2015 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,625 | $179.13 | 33,030 |
| Aug 13, 2015 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 23,000 | $52.03 | 46,299 |
| Aug 13, 2015 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,000 | $52.03 | 41,439 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.